学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
CRITERIA FOR DISK SUSCEPTIBILITY TESTS AND QUALITY-CONTROL GUIDELINES FOR THE CEFOPERAZONE-SULBACTAM COMBINATION
被引:35
作者
:
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
BARRY, AL
JONES, RN
论文数:
0
引用数:
0
h-index:
0
JONES, RN
机构
:
来源
:
JOURNAL OF CLINICAL MICROBIOLOGY
|
1988年
/ 26卷
/ 01期
关键词
:
D O I
:
10.1128/JCM.26.1.13-17.1988
中图分类号
:
Q93 [微生物学];
学科分类号
:
071005 ;
100705 ;
摘要
:
引用
收藏
页码:13 / 17
页数:5
相关论文
共 16 条
[1]
COMPARATIVE ACTIVITY OF BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH BETA-LACTAMS AGAINST BETA-LACTAMASE-PRODUCING ANAEROBES
APPELBAUM, PC
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106
APPELBAUM, PC
JACOBS, MR
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106
JACOBS, MR
SPANGLER, SK
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106
SPANGLER, SK
YAMABE, S
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106
YAMABE, S
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1986,
30
(05)
: 789
-
791
[2]
QUALITY-CONTROL LIMITS FOR MICRODILUTION SUSCEPTIBILITY TESTS WITH AZTREONAM, IMIPENEM, CEFTRIAXONE, CEFTAZIDIME, CEFTIZOXIME, CEFUROXIME, AND CEFONICID
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
BARRY, AL
GAVAN, TL
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
GAVAN, TL
JONES, RN
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
JONES, RN
AYERS, LW
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
AYERS, LW
FUCHS, PC
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
FUCHS, PC
GERLACH, EH
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
GERLACH, EH
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
THORNSBERRY, C
[J].
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE,
1987,
7
(01)
: 83
-
87
[3]
INVITRO SUSCEPTIBILITY OF THE BACTEROIDES-FRAGILIS GROUP TO CEFOPERAZONE, AMPICILLIN, TICARCILLIN AND AMOXICILLIN COMBINED WITH BETA-LACTAMASE INHIBITORS
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
BARRY, AL
JONES, RN
论文数:
0
引用数:
0
h-index:
0
JONES, RN
PACKER, RR
论文数:
0
引用数:
0
h-index:
0
PACKER, RR
[J].
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,
1986,
17
(01)
: 125
-
126
[4]
ACTIVITY OF CEFOPERAZONE AND 2 BETA-LACTAMASE INHIBITORS, SULBACTAM AND CLAVULANIC ACID, AGAINST BACTEROIDES SPP CORRELATED WITH BETA-LACTAMASE PRODUCTION
CROSBY, MA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV VERMONT,COLL MED,DEPT MED,BURLINGTON,VT 05405
CROSBY, MA
GUMP, DW
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV VERMONT,COLL MED,DEPT MED,BURLINGTON,VT 05405
GUMP, DW
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1982,
22
(03)
: 398
-
405
[5]
CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION
ENGLISH, AR
论文数:
0
引用数:
0
h-index:
0
ENGLISH, AR
RETSEMA, JA
论文数:
0
引用数:
0
h-index:
0
RETSEMA, JA
GIRARD, AE
论文数:
0
引用数:
0
h-index:
0
GIRARD, AE
LYNCH, JE
论文数:
0
引用数:
0
h-index:
0
LYNCH, JE
BARTH, WE
论文数:
0
引用数:
0
h-index:
0
BARTH, WE
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1978,
14
(03)
: 414
-
419
[6]
FU KP, 1980, J ANTIMICROB CHEMOTH, V7, P287
[7]
QUALITY-CONTROL LIMITS FOR AMPICILLIN, CARBENICILLIN, MEZLOCILLIN, AND PIPERACILLIN DISK DIFFUSION SUSCEPTIBILITY TESTS - A COLLABORATIVE STUDY
GAVAN, TL
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
GAVAN, TL
JONES, RN
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
JONES, RN
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
BARRY, AL
FUCHS, PC
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
FUCHS, PC
GERLACH, EH
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
GERLACH, EH
MATSEN, JM
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
MATSEN, JM
RELLER, LB
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
RELLER, LB
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
THORNSBERRY, C
THRUPP, LD
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
THRUPP, LD
[J].
JOURNAL OF CLINICAL MICROBIOLOGY,
1981,
14
(01)
: 67
-
72
[8]
INVITRO ANTIMICROBIAL SPECTRUM, OCCURRENCE OF SYNERGY, AND RECOMMENDATIONS FOR DILUTION SUSCEPTIBILITY TESTING CONCENTRATIONS OF THE CEFOPERAZONE-SULBACTAM COMBINATION
JONES, RN
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
JONES, RN
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
BARRY, AL
PACKER, RR
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
PACKER, RR
GREGORY, WW
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
GREGORY, WW
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
THORNSBERRY, C
[J].
JOURNAL OF CLINICAL MICROBIOLOGY,
1987,
25
(09)
: 1725
-
1729
[9]
THE CEFOPERAZONE-SULBACTAM COMBINATION - INVITRO QUALITIES INCLUDING BETA-LACTAMASE STABILITY, ANTIMICROBIAL ACTIVITY, AND INTERPRETIVE CRITERIA FOR DISK DIFFUSION TESTS
JONES, RN
论文数:
0
引用数:
0
h-index:
0
机构:
CTR DIS CONTROL,ATLANTA,GA 30333
CTR DIS CONTROL,ATLANTA,GA 30333
JONES, RN
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
机构:
CTR DIS CONTROL,ATLANTA,GA 30333
CTR DIS CONTROL,ATLANTA,GA 30333
BARRY, AL
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
机构:
CTR DIS CONTROL,ATLANTA,GA 30333
CTR DIS CONTROL,ATLANTA,GA 30333
THORNSBERRY, C
WILSON, HW
论文数:
0
引用数:
0
h-index:
0
机构:
CTR DIS CONTROL,ATLANTA,GA 30333
CTR DIS CONTROL,ATLANTA,GA 30333
WILSON, HW
[J].
AMERICAN JOURNAL OF CLINICAL PATHOLOGY,
1985,
84
(04)
: 496
-
504
[10]
INVITRO ANTIMICROBIAL ACTIVITY OF CEFOPERAZONE SULBACTAM COMBINATIONS AGAINST 554 CLINICAL ISOLATES INCLUDING A REVIEW AND BETA-LACTAMASE STUDIES
JONES, RN
论文数:
0
引用数:
0
h-index:
0
JONES, RN
WILSON, HW
论文数:
0
引用数:
0
h-index:
0
WILSON, HW
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
THORNSBERRY, C
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
BARRY, AL
[J].
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE,
1985,
3
(06)
: 489
-
499
←
1
2
→
共 16 条
[1]
COMPARATIVE ACTIVITY OF BETA-LACTAMASE INHIBITORS YTR 830, CLAVULANATE, AND SULBACTAM COMBINED WITH BETA-LACTAMS AGAINST BETA-LACTAMASE-PRODUCING ANAEROBES
APPELBAUM, PC
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106
APPELBAUM, PC
JACOBS, MR
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106
JACOBS, MR
SPANGLER, SK
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106
SPANGLER, SK
YAMABE, S
论文数:
0
引用数:
0
h-index:
0
机构:
CASE WESTERN RESERVE UNIV,DEPT PATHOL,CLEVELAND,OH 44106
YAMABE, S
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1986,
30
(05)
: 789
-
791
[2]
QUALITY-CONTROL LIMITS FOR MICRODILUTION SUSCEPTIBILITY TESTS WITH AZTREONAM, IMIPENEM, CEFTRIAXONE, CEFTAZIDIME, CEFTIZOXIME, CEFUROXIME, AND CEFONICID
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
BARRY, AL
GAVAN, TL
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
GAVAN, TL
JONES, RN
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
JONES, RN
AYERS, LW
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
AYERS, LW
FUCHS, PC
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
FUCHS, PC
GERLACH, EH
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
GERLACH, EH
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
机构:
ST VINCENT HOSP & MED CTR,PORTLAND,OR
THORNSBERRY, C
[J].
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE,
1987,
7
(01)
: 83
-
87
[3]
INVITRO SUSCEPTIBILITY OF THE BACTEROIDES-FRAGILIS GROUP TO CEFOPERAZONE, AMPICILLIN, TICARCILLIN AND AMOXICILLIN COMBINED WITH BETA-LACTAMASE INHIBITORS
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
BARRY, AL
JONES, RN
论文数:
0
引用数:
0
h-index:
0
JONES, RN
PACKER, RR
论文数:
0
引用数:
0
h-index:
0
PACKER, RR
[J].
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY,
1986,
17
(01)
: 125
-
126
[4]
ACTIVITY OF CEFOPERAZONE AND 2 BETA-LACTAMASE INHIBITORS, SULBACTAM AND CLAVULANIC ACID, AGAINST BACTEROIDES SPP CORRELATED WITH BETA-LACTAMASE PRODUCTION
CROSBY, MA
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV VERMONT,COLL MED,DEPT MED,BURLINGTON,VT 05405
CROSBY, MA
GUMP, DW
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV VERMONT,COLL MED,DEPT MED,BURLINGTON,VT 05405
GUMP, DW
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1982,
22
(03)
: 398
-
405
[5]
CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION
ENGLISH, AR
论文数:
0
引用数:
0
h-index:
0
ENGLISH, AR
RETSEMA, JA
论文数:
0
引用数:
0
h-index:
0
RETSEMA, JA
GIRARD, AE
论文数:
0
引用数:
0
h-index:
0
GIRARD, AE
LYNCH, JE
论文数:
0
引用数:
0
h-index:
0
LYNCH, JE
BARTH, WE
论文数:
0
引用数:
0
h-index:
0
BARTH, WE
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1978,
14
(03)
: 414
-
419
[6]
FU KP, 1980, J ANTIMICROB CHEMOTH, V7, P287
[7]
QUALITY-CONTROL LIMITS FOR AMPICILLIN, CARBENICILLIN, MEZLOCILLIN, AND PIPERACILLIN DISK DIFFUSION SUSCEPTIBILITY TESTS - A COLLABORATIVE STUDY
GAVAN, TL
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
GAVAN, TL
JONES, RN
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
JONES, RN
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
BARRY, AL
FUCHS, PC
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
FUCHS, PC
GERLACH, EH
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
GERLACH, EH
MATSEN, JM
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
MATSEN, JM
RELLER, LB
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
RELLER, LB
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
THORNSBERRY, C
THRUPP, LD
论文数:
0
引用数:
0
h-index:
0
机构:
KAISER FDN LABS,DEPT PATHOL,CLACKAMAS,OR 97015
THRUPP, LD
[J].
JOURNAL OF CLINICAL MICROBIOLOGY,
1981,
14
(01)
: 67
-
72
[8]
INVITRO ANTIMICROBIAL SPECTRUM, OCCURRENCE OF SYNERGY, AND RECOMMENDATIONS FOR DILUTION SUSCEPTIBILITY TESTING CONCENTRATIONS OF THE CEFOPERAZONE-SULBACTAM COMBINATION
JONES, RN
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
JONES, RN
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
BARRY, AL
PACKER, RR
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
PACKER, RR
GREGORY, WW
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
GREGORY, WW
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
机构:
PFIZER PHARMACEUT INC,NEW YORK,NY 10017
THORNSBERRY, C
[J].
JOURNAL OF CLINICAL MICROBIOLOGY,
1987,
25
(09)
: 1725
-
1729
[9]
THE CEFOPERAZONE-SULBACTAM COMBINATION - INVITRO QUALITIES INCLUDING BETA-LACTAMASE STABILITY, ANTIMICROBIAL ACTIVITY, AND INTERPRETIVE CRITERIA FOR DISK DIFFUSION TESTS
JONES, RN
论文数:
0
引用数:
0
h-index:
0
机构:
CTR DIS CONTROL,ATLANTA,GA 30333
CTR DIS CONTROL,ATLANTA,GA 30333
JONES, RN
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
机构:
CTR DIS CONTROL,ATLANTA,GA 30333
CTR DIS CONTROL,ATLANTA,GA 30333
BARRY, AL
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
机构:
CTR DIS CONTROL,ATLANTA,GA 30333
CTR DIS CONTROL,ATLANTA,GA 30333
THORNSBERRY, C
WILSON, HW
论文数:
0
引用数:
0
h-index:
0
机构:
CTR DIS CONTROL,ATLANTA,GA 30333
CTR DIS CONTROL,ATLANTA,GA 30333
WILSON, HW
[J].
AMERICAN JOURNAL OF CLINICAL PATHOLOGY,
1985,
84
(04)
: 496
-
504
[10]
INVITRO ANTIMICROBIAL ACTIVITY OF CEFOPERAZONE SULBACTAM COMBINATIONS AGAINST 554 CLINICAL ISOLATES INCLUDING A REVIEW AND BETA-LACTAMASE STUDIES
JONES, RN
论文数:
0
引用数:
0
h-index:
0
JONES, RN
WILSON, HW
论文数:
0
引用数:
0
h-index:
0
WILSON, HW
THORNSBERRY, C
论文数:
0
引用数:
0
h-index:
0
THORNSBERRY, C
BARRY, AL
论文数:
0
引用数:
0
h-index:
0
BARRY, AL
[J].
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE,
1985,
3
(06)
: 489
-
499
←
1
2
→